Sign in

CIK 0001874252

  • Emerging growth company

Quantum Cyber N.V.

Sign in to watch
Ticker
QUCY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
Operating
Phone
+49 61315542860
Business address
ROBERT KOCH STRASSE 50, MAINZ, Germany
Former names
MAINZ BIOMED N.V., Mainz Biomed B.V.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-08 Ben-Tzvi Avraham Director Grant or award +137,141 139,141
2026-05-08 NATAN DAVID Director Grant or award +137,141 137,141
2026-04-22 Lazar David E. Chief Executive Officer Grant or award · Series D Preferred Shares +1,000,000 $1.50 $1.5M 1,000,000
2026-04-22 Lazar David E. Chief Executive Officer Grant or award · Series E Preferred Shares +1,000,000 $1.50 $1.5M 1,000,000
2026-02-13 Lazar David E. Director Grant or award · Series A Preferred Shares +1,000,000 1,000,000
2026-02-13 Lazar David E. Director Grant or award · Series B Preferred Shares +1,000,000 1,000,000
2026-02-13 Lazar David E. Director Grant or award · Series C Preferred Shares +1,000,000 1,000,000
2026-02-13 Caragol William J Chief Financial Officer Grant or award +290,000 367,899
2026-02-13 Dreismann Heinrich Director Grant or award +45,000 64,700
2026-02-13 Tibbitts Gregory J Director Grant or award +45,000 55,875
2026-02-13 BAECHLER GUIDO Chief Executive Officer Grant or award +440,000 605,058
2025-10-17 Donahue Kevin Michael 10% owner Purchase +685,000 $1.51 $1.0M 685,000
2025-10-17 Donahue Kevin Michael 10% owner Purchase +643,850 $402,000.00 $258.8B 643,850

Page 2 of 2 · 33 trades